Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor + Ruxolitinib in JAKi Treatment-Naïve Patients With Myelofibrosis"

205 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login